Citadel Group — Major Shareholding Notification 2023

Sep 1, 2023

National Storage Mechanism | Additional information

RNS Number : 1150L

Citadel Group

01 September 2023

Ap27

FORM 8.3

IRISH TAKEOVER PANEL

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.             KEY INFORMATION

(a)   Full name of discloser	Citadel Group
(b)   Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.	N/A
(c)   Name of offeror/offeree in relation to whose relevant securities this form relates Use a separate form for each offeror/offeree	HORIZON THERAPEUTICS PLC
(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)	N/A
(e)   Date position held/dealing undertaken For an opening position disclosure, state the latest practicable date prior to the disclosure	31 August 2023
(f)    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A"	N/A

2.             INTERESTS AND SHORT POSITIONS

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Ap28

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

Class of relevant security (Note 3)	Common Stock ISIN IE00BQPVQZ61
	Interests		Short positions
Number	%	Number	%
(1)   Relevant securities owned and/or controlled	5,829,883	2.54	0	0.00
(2)   Cash-settled derivatives	607,503	0.26	0	0.00
(3)   Stock-settled derivatives (including options) and agreements to purchase/ sell	870,400	0.38	3,253,800	1.42
Total	7,307,786	3.19	3,253,800	1.42

All interests and all short positions should be disclosed.

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

3.             DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)           Purchases and sales

Class of relevant security	Purchase/sale	Number of securities	Price per unit (Note 5)
Common	Buy Transaction	24	112.8800 USD
Common	Buy Transaction	86	112.9300 USD
Common	Buy Transaction	22	112.9473 USD
Common	Buy Transaction	43	112.9786 USD
Common	Buy Transaction	200	112.9950 USD
Common	Buy Transaction	201	113.1439 USD
Common	Sell Transaction	14,427	112.8677 USD
Common	Sell Transaction	5,770	112.8677 USD
Common	Sell Transaction	3,608	112.8677 USD
Common	Sell Transaction	100	112.9900 USD
Common	Sell Transaction	200	113.0025 USD
Common	Sell Transaction	39,949	113.0056 USD
Common	Sell Transaction	15,983	113.0057 USD
Common	Sell Transaction	9,994	113.0058 USD
Common	Sell Transaction	1,116	113.0105 USD
Common	Sell Transaction	690	113.0107 USD
Common	Sell Transaction	2,794	113.0109 USD
Common	Sell Transaction	841	113.0164 USD
Common	Sell Transaction	1,317	113.0176 USD
Common	Sell Transaction	3,342	113.0178 USD
Common	Sell Transaction	5,500	113.0250 USD
Common	Sell Transaction	7,930	113.0326 USD
Common	Sell Transaction	4,967	113.0327 USD
Common	Sell Transaction	19,846	113.0327 USD
Common	Sell Transaction	695	113.0342 USD
Common	Sell Transaction	1,116	113.0344 USD
Common	Sell Transaction	2,789	113.0345 USD
Common	Sell Transaction	26	113.0396 USD
Common	Sell Transaction	674	113.0400 USD
Common	Sell Transaction	2,324	113.0404 USD
Common	Sell Transaction	9,276	113.0405 USD
Common	Sell Transaction	3,726	113.0407 USD
Common	Sell Transaction	219	113.0444 USD
Common	Sell Transaction	1,540	113.0456 USD
Common	Sell Transaction	3,818	113.0461 USD
Common	Sell Transaction	942	113.0468 USD
Common	Sell Transaction	100	113.0500 USD
Common	Sell Transaction	89	113.0502 USD
Common	Sell Transaction	366	113.0513 USD
Common	Sell Transaction	145	113.0517 USD
Common	Sell Transaction	6	113.0600 USD
Common	Sell Transaction	917	113.0676 USD
Common	Sell Transaction	100	113.1200 USD

Ap29

(b)           Cash-settled derivative transactions

Class of relevant security	Product description e.g. CFD	Nature of dealing e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position	Number of reference securities (Note 6)	Price per unit (Note 5)
Common	CFD	Reducing long position	586	113.0271 USD
Common	CFD	Reducing long position	1,218	113.0317 USD
Common	CFD	Reducing long position	972	113.0323 USD
Common	CFD	Reducing long position	2,619	113.0325 USD
Common	CFD	Reducing long position	587	113.0337 USD
Common	CFD	Reducing long position	166	113.0427 USD
Common	CFD	Reducing long position	53	113.0481 USD

(c)           Stock-settled derivative transactions (including options)

(i)            Writing, selling, purchasing or varying

Class of relevant security	Product description e.g. call option	Writing, purchasing, selling, varying etc.	Number of securities to which option relates (Note 6)	Exercise price per unit	Type e.g. American, European etc.	Expiry date	Option money paid/ received per unit
Common	Call Option	Buy Transaction	2,695	115.0000 USD	American	2023-Sep-01	0.0500 USD
Common	Call Option	Sell Transaction	466	120.0000 USD	American	2023-Dec-15	0.1000 USD

(ii)           Exercise

Class of relevant security	Product description e.g. call option	Exercising/ exercised against	Number of securities	Exercise price per unit (Note 5)

(d)           Other dealings (including transactions in respect of new securities) (Note 3)

Class of relevant security	Nature of dealing e.g. subscription, conversion, exercise	Details	Price per unit (if applicable) (Note 5)

Ap30

4.             OTHER INFORMATION

(a)           Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer. Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
None

(b)           Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None

(c)           Attachments

Is a Supplemental Form 8 attached?	YES

Date of disclosure	1 September 2023
Contact name	Paula Sharp
Telephone number	020 7645 9700

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1.             KEY INFORMATION

Full name of person making disclosure:	Citadel Group
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:	HORIZON THERAPEUTICS PLC

2.             STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security	Product description e.g. call option	Written or purchased	Number of securities to which option or derivative relates	Exercise price per unit	Type e.g. American, European etc.	Expiry date
Common	Put Option	Purchased	-5,000	90.0 USD	American	15/09/2023
Common	Put Option	Purchased	-10,000	98.0 USD	American	01/09/2023
Common	Put Option	Purchased	-200,000	75.0 USD	American	17/11/2023
Common	Call Option	Purchased	27,300	115.0 USD	American	15/09/2023
Common	Put Option	Purchased	-280,000	80.0 USD	American	15/12/2023
Common	Call Option	Purchased	242,200	115.0 USD	American	01/09/2023
Common	Put Option	Purchased	-3,100	99.5 USD	American	01/09/2023
Common	Put Option	Purchased	-100	55.0 USD	American	19/01/2024
Common	Put Option	Purchased	-958,900	100.0 USD	American	19/01/2024
Common	Put Option	Purchased	-12,900	70.0 USD	American	19/01/2024
Common	Put Option	Purchased	-3,800	100.0 USD	American	17/11/2023
Common	Put Option	Purchased	-300,000	110.0 USD	American	19/01/2024
Common	Put Option	Purchased	-400	104.0 USD	American	01/09/2023
Common	Put Option	Purchased	-15,000	102.0 USD	American	01/09/2023
Common	Put Option	Purchased	-1,500	90.0 USD	American	17/11/2023
Common	Put Option	Sold	700	60.0 USD	American	17/11/2023
Common	Put Option	Sold	62,500	90.0 USD	American	19/01/2024
Common	Call Option	Sold	-900	115.0 USD	American	15/03/2024
Common	Put Option	Sold	9,400	95.0 USD	American	17/11/2023
Common	Call Option	Sold	-50,000	120.0 USD	American	19/01/2024
Common	Call Option	Sold	-319,600	106.0 USD	American	01/09/2023
Common	Put Option	Sold	442,800	60.0 USD	American	19/01/2024
Common	Put Option	Sold	32,800	55.0 USD	American	17/11/2023
Common	Call Option	Sold	-200,000	110.0 USD	American	20/10/2023
Common	Put Option	Sold	700	50.0 USD	American	19/01/2024
Common	Call Option	Sold	-250,000	110.0 USD	American	15/09/2023
Common	Call Option	Sold	-10,900	115.0 USD	American	17/01/2025
Common	Call Option	Sold	-100,000	110.0 USD	American	19/01/2024
Common	Call Option	Sold	-147,400	120.0 USD	American	15/12/2023
Common	Put Option	Sold	52,000	55.0 USD	American	15/09/2023
Common	Call Option	Sold	-2,300	120.0 USD	American	15/09/2023
Common	Call Option	Sold	-30,000	105.0 USD	American	15/09/2023
Common	Call Option	Sold	-352,000	115.0 USD	American	19/01/2024

3.             AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

Ap33

4.             RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS' AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ITPUPUAPBUPWURG